112 related articles for article (PubMed ID: 21255571)
1. The tumor suppressor RECK interferes with HER-2/Neu dimerization and attenuates its oncogenic signaling.
Hong KJ; Hsu MC; Hou MF; Hung WC
FEBS Lett; 2011 Feb; 585(4):591-5. PubMed ID: 21255571
[TBL] [Abstract][Full Text] [Related]
2. [Expression and significance of HER-2/neu mRNA and RECK mRNA in breast carcinoma tissue].
Shen B; Chen J; Zheng MQ; Xu XY; Wei D; Feng JF
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Aug; 26(4):279-81. PubMed ID: 23189844
[TBL] [Abstract][Full Text] [Related]
3. HER-2/neu represses the metastasis suppressor RECK via ERK and Sp transcription factors to promote cell invasion.
Hsu MC; Chang HC; Hung WC
J Biol Chem; 2006 Feb; 281(8):4718-25. PubMed ID: 16377629
[TBL] [Abstract][Full Text] [Related]
4. GRB-7 facilitates HER-2/Neu-mediated signal transduction and tumor formation.
Bai T; Luoh SW
Carcinogenesis; 2008 Mar; 29(3):473-9. PubMed ID: 17916906
[TBL] [Abstract][Full Text] [Related]
5. [SUCI02 inhibits HER-2/neu receptor tyrosine kinase phosphorylation and growth of HER-2/neu-overexpressing breast cancer cells].
Zhu XF; Liu ZC; Xie BF; Cai LL; Yang DJ
Ai Zheng; 2003 Aug; 22(8):790-4. PubMed ID: 12917021
[TBL] [Abstract][Full Text] [Related]
6. HER-2/neu transcriptionally activates Jab1 expression via the AKT/beta-catenin pathway in breast cancer cells.
Hsu MC; Chang HC; Hung WC
Endocr Relat Cancer; 2007 Sep; 14(3):655-67. PubMed ID: 17914096
[TBL] [Abstract][Full Text] [Related]
7. RECK inhibits stemness gene expression and tumorigenicity of gastric cancer cells by suppressing ADAM-mediated Notch1 activation.
Hong KJ; Wu DC; Cheng KH; Chen LT; Hung WC
J Cell Physiol; 2014 Feb; 229(2):191-201. PubMed ID: 23881612
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of neu/HER-2 by interferon-gamma in prostate cancer cells.
Kominsky SL; Hobeika AC; Lake FA; Torres BA; Johnson HM
Cancer Res; 2000 Jul; 60(14):3904-8. PubMed ID: 10919667
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological inhibition of fatty acid synthase (FAS): a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation.
Menendez JA; Mehmi I; Verma VA; Teng PK; Lupu R
Mol Carcinog; 2004 Nov; 41(3):164-78. PubMed ID: 15390078
[TBL] [Abstract][Full Text] [Related]
10. HER-2/neu mediates oncogenic transformation via altered CREB expression and function.
Steven A; Leisz S; Massa C; Iezzi M; Lattanzio R; Lamolinara A; Bukur J; Müller A; Hiebl B; Holzhausen HJ; Seliger B
Mol Cancer Res; 2013 Nov; 11(11):1462-77. PubMed ID: 24025972
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells.
Zhou BP; Liao Y; Xia W; Spohn B; Lee MH; Hung MC
Nat Cell Biol; 2001 Mar; 3(3):245-52. PubMed ID: 11231573
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of Ser78 of Hsp27 correlated with HER-2/neu status and lymph node positivity in breast cancer.
Zhang D; Wong LL; Koay ES
Mol Cancer; 2007 Aug; 6():52. PubMed ID: 17697330
[TBL] [Abstract][Full Text] [Related]
13. The tumor suppression activity of E1A in HER-2/neu-overexpressing breast cancer.
Chang JY; Xia W; Shao R; Sorgi F; Hortobagyi GN; Huang L; Hung MC
Oncogene; 1997 Feb; 14(5):561-8. PubMed ID: 9053854
[TBL] [Abstract][Full Text] [Related]
14. Proteomics of breast cancer: enhanced expression of cytokeratin19 in human epidermal growth factor receptor type 2 positive breast tumors.
Zhang DH; Tai LK; Wong LL; Sethi SK; Koay ES
Proteomics; 2005 May; 5(7):1797-805. PubMed ID: 15825149
[TBL] [Abstract][Full Text] [Related]
15. HER-2/neu raises SHP-2, stops IFN-gamma anti-proliferation in bladder cancer.
Su WP; Tu IH; Hu SW; Yeh HH; Shieh DB; Chen TY; Su WC
Biochem Biophys Res Commun; 2007 Apr; 356(1):181-6. PubMed ID: 17346677
[TBL] [Abstract][Full Text] [Related]
16. Heregulin-triggered Her-2/neu signaling enhances nuclear accumulation of p21WAF1/CIP1 and protects breast cancer cells from cisplatin-induced genotoxic damage.
Menendez JA; Mehmi I; Lupu R
Int J Oncol; 2005 Mar; 26(3):649-59. PubMed ID: 15703820
[TBL] [Abstract][Full Text] [Related]
17. [Effect of genistein on expression of angiogenesis related factors in HER-2/neu-overexpressing breast cancer cells].
Yu XP; Mi MT; Zhu JD
Shi Yan Sheng Wu Xue Bao; 2004 Jun; 37(3):251-3. PubMed ID: 15323430
[TBL] [Abstract][Full Text] [Related]
18. The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells.
Pegram MD; Finn RS; Arzoo K; Beryt M; Pietras RJ; Slamon DJ
Oncogene; 1997 Jul; 15(5):537-47. PubMed ID: 9247307
[TBL] [Abstract][Full Text] [Related]
19. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
Hussein MR; Abd-Elwahed SR; Abdulwahed AR
Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
[TBL] [Abstract][Full Text] [Related]
20. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
